BCL2 and neoplasm: Immunoreactivity of the tumor for 34βE12, bcl-2, p63, p53, and Ki67 (Figure 2A, B, C, D), coupled with the absence of negative staining for PSA and cytokeratins 7 and 20, strongly favored a diagnosis of BCC [2,3].